
USFDA APPLICATION NUMBER - 18965 / DOSAGE - SUSPENSION;ORAL - 25MG/ML
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| NAPROXEN(UNII: 57Y76R9ATQ) (NAPROXEN - UNII:57Y76R9ATQ) | NAPROXEN | 125mg in 5 |
Inactive Ingredients
| Ingredient Name | Allegis Holdings, LLC | Entreprises ImportFAB Inc. | Key Therapeutics, LLC | Palmetto Pharmaceuticals |
|---|---|---|---|---|
| FD&C YELLOW NO. 6(H77VEI93A8) | ||||
| FUMARIC ACID(88XHZ13131) | ||||
| MAGNESIUM ALUMINUM SILICATE(6M3P64V0NC) | ||||
| METHYLPARABEN(A2I8C7HI9T) | ||||
| ORANGE(5EVU04N5QU) | ||||
| PINEAPPLE(2A88ZO081O) | ||||
| SODIUM CHLORIDE(451W47IQ8X) | ||||
| SORBITOL(506T60A25R) | ||||
| SUCROSE(C151H8M554) | ||||
| WATER(059QF0KO0R) |